Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinoma-Reference-Cited by-同舟云学术

Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinoma

Published:2022-02 Issue: Volume:526 Page:346-351
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Fisk J. Nicholas^ORCID,Mahal Amandeep R.^ORCID,Dornburg Alex,Gaffney Stephen G.^ORCID,Aneja Sanjay,Contessa Joseph N.,Rimm David,Yu James B.^ORCID,Townsend Jeffrey P.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Are 90% of deaths from cancer caused by metastases?;Dillekås;Cancer Med,2019

2. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review;Stewart;Transl. Lung Cancer Res.,2015

3. Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors;Ortiz-Cuaran;Clin. Cancer Res.,2016

4. Genotype-fitness maps of EGFR-mutant lung adenocarcinoma chart the evolutionary landscape of resistance for combination therapy optimization;Bolan;Cell Syst,2020

5. Genetic determinants of EGFR-driven lung cancer growth and therapeutic response in vivo;Foggetti;Cancer Discov.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis;Mathematical Biosciences;2023-12

2. Treatment of evolving cancers will require dynamic decision support;Annals of Oncology;2023-10

3. Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues;Cell Genomics;2023-09

4. Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools;Journal of Molecular Evolution;2023-05-29

5. Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes;Cancers;2022-12-20